A safety and effectiveness evaluation of RefluxStop in the treatment of acid reflux comparing large and small hiatal hernia groups: results from 99 patients in Switzerland with up to 4-years follow-up - Takeaways - MDSpire

A safety and effectiveness evaluation of RefluxStop in the treatment of acid reflux comparing large and small hiatal hernia groups: results from 99 patients in Switzerland with up to 4-years follow-up

  • By

  • Yves Borbély

  • Dino Kroell

  • Sarah Gerber

  • Yannick Fringeli

  • Ioannis Linas

  • Joerg Zehetner

  • May 3, 2025

  • 0 min

Share

  • 1

    Gastroesophageal reflux disease (GERD) affects nearly 20% of the US population weekly and can lead to severe complications, including esophageal adenocarcinoma.

  • 2

    Current treatments like proton pump inhibitors (PPIs) do not address the underlying causes of reflux, leading to persistent symptoms in many patients.

  • 3

    Large hiatal hernias present unique challenges in managing reflux, with existing surgical options often resulting in high rates of reherniation.

  • 4

    The RefluxStop procedure aims to prevent reherniation by restoring the antireflux barrier without encircling the food conduit, maintaining anatomical stability.

  • 5

    This study evaluates the safety and effectiveness of the RefluxStop device in GERD patients with small and large hiatal hernias over a follow-up period of up to 4 years.

Original Source(s)

Related Content